Capturing the Additional Cardiovascular Benefits of SGLT2 Inhibitors and GLP-1 Receptor Agonists Beyond the Control of Traditional Risk Factors in People With Diabetes

Authors: Niu, Shu ¹, Guan, Dawei ¹, Shi, Lizheng ², Fonseca, Vivian ³, Svensson, Mikael ^{1, 4}, Ali, Mohammed K. ^{5, 6}, Sun, Yan V. ⁷, Hu, Xin ⁸, Su, Chang ⁹, Yang, Carl ¹⁰, Shao, Hui ^{1, 5, 6, ∗}

Source: In Value in Health January 2025

DCRM 2.0: Multispecialty practice recommendations for the management of diabetes, cardiorenal, and metabolic diseases

Authors: Handelsman, Yehuda, Anderson, John E., Bakris, George L., Ballantyne, Christie M., Bhatt, Deepak L., Bloomgarden, Zachary T., Bozkurt, Biykem, Budoff, Matthew J., Butler, Javed, Cherney, David Z.I., DeFronzo, Ralph A., Del Prato, Stefano, Eckel, Robert H., Filippatos, Gerasimos, Fonarow, Gregg C., Fonseca, Vivian A., Garvey, W. Timothy, Giorgino, Francesco, Grant, Peter J., Green, Jennifer B., Greene, Stephen J., Groop, Per-Henrik, Grunberger, George, Jastreboff, Ania M., Jellinger, Paul S., Khunti, Kamlesh, Klein, Samuel, Kosiborod, Mikhail N., Kushner, Pamela, Leiter, Lawrence A., Lepor, Norman E., Mantzoros, Christos S., Mathieu, Chantal, Mende, Christian W., Michos, Erin D., Morales, Javier, Plutzky, Jorge, Pratley, Richard E., Ray, Kausik K., Rossing, Peter, Sattar, Naveed, Schwarz, Peter E.H., Standl, Eberhard, Steg, P. Gabriel, Tokgözoğlu, Lale, Tuomilehto, Jaakko, Umpierrez, Guillermo E., Valensi, Paul, Weir, Matthew R., Wilding, John, Wright, Eugene E., Jr.

Source: In Metabolism October 2024 159

Cluster of differentiation molecules in the metabolic syndrome

Authors: Duc Nguyen, Hai, Ardeshir, Amir, Fonseca, Vivian A., Kim, Woong-Ki

Source: In Clinica Chimica Acta 15 July 2024 561

Mourning, reconstruction, and the future after heritage catastrophes: A comparative social science perspective agenda

Authors: Isnart, Cyril, Raulin, Anne, Menezes, Renata, Pereira, Edmundo, Pinto, Diana de Souza, Pinheiro, Thaís Mayumi, Loir-Mongazon, Elisabeth, Girard, Garance, Goacolou, Emma, Fonseca, Vivian Luiz

Source: In Journal of Cultural Heritage January-February 2024 65:199-205

Sex Differences in Cardiovascular Risk Associated With Prediabetes and Undiagnosed Diabetes

Authors: Yoshida, Yilin, Chen, Zhipeng, Fonseca, Vivian A., Mauvais-Jarvis, Franck

Source: In American Journal of Preventive Medicine November 2023 65(5):854-862

The Impact of Reimbursement for Non-Face-to-Face Chronic Care Management on Health Utilization Among Patients With Type 2 Diabetes in Louisiana

Authors: Shao, Yixue, Stoecker, Charles, Hong, Dongzhe, Nauman, Elizabeth, Fonseca, Vivian, Hu, Gang, Bazzano, Alessandra N., Kabagambe, Edmond K., Shi, Lizheng

Source: In Value in Health May 2023 26(5):676-684

A prediction model on incident ESKD among individuals with T2D and CKD

Authors: Lin, Yilu, Shao, Hui, Fonseca, Vivian, Anderson, Amanda H., Batuman, Vecihi, Shi, Lizheng

Source: In Journal of Diabetes and Its Complications April 2023 37(4)

A prediction model of CKD progression among individuals with type 2 diabetes in the United States

Authors: Lin, Yilu, Shao, Hui, Fonseca, Vivian, Anderson, Amanda H., Batuman, Vecihi, Shi, Lizheng

Source: In Journal of Diabetes and Its Complications March 2023 37(3)

Early intervention and intensive management of patients with diabetes, cardiorenal, and metabolic diseases

Authors: Handelsman, Yehuda, Butler, Javed, Bakris, George L., DeFronzo, Ralph A., Fonarow, Gregg C., Green, Jennifer B., Grunberger, George, Januzzi, James L., Jr, Klein, Samuel, Kushner, Pamela R., McGuire, Darren K., Michos, Erin D., Morales, Javier, Pratley, Richard E., Weir, Matthew R., Wright, Eugene, Fonseca, Vivian A.

Source: In Journal of Diabetes and Its Complications February 2023 37(2)

Using modern risk engines and machine learning/artificial intelligence to predict diabetes complications: A focus on the BRAVO model

Authors: Shao, Hui, Shi, Lizheng, Lin, Yilu, Fonseca, Vivian

Source: In Journal of Diabetes and Its Complications November 2022 36(11)

The trial to assess chelation therapy 2 (TACT2): Rationale and design

Authors: Lamas, Gervasio A., Anstrom, Kevin J., Navas-Acien, Ana, Boineau, Robin, Kim, Hwasoon, Rosenberg, Yves, Stylianou, Mario, Jones, Teresa L.Z., Joubert, Bonnie R., Santella, Regina M., Escolar, Esteban, Aude, Y. Wady, Fonseca, Vivian, Elliott, Thomas, Lewis, Eldrin F., Farkouh, Michael E., Nathan, David M., Mon, Ana C., Gosnell, Leigh, Newman, Jonathan D., Mark, Daniel B.

Source: In American Heart Journal October 2022 252:1-11

A machine learning approach identifies modulators of heart failure hospitalization prevention among patients with type 2 diabetes: A revisit to the ACCORD trial

Authors: Kianmehr, Hamed, Guo, Jingchuan, Lin, Yilu, Luo, Jing, Cushman, William, Shi, Lizheng, Fonseca, Vivian, Shao, Hui

Source: In Journal of Diabetes and Its Complications September 2022 36(9)

Clinical Need for Point-of-Care Testing for Diabetes in Clinical and Laboratory Improvement Amendments–Waived Settings.

Authors: Kushner, Pamela R.¹ (AUTHOR) pamkushner@hotmail.com, Fonseca, Vivian² (AUTHOR), Nichols, James H.³ (AUTHOR), Shubrook, Jay H.⁴ (AUTHOR), Miller, Eden⁵ (AUTHOR), Wright, Eugene⁶ (AUTHOR), DeFilippi, Christopher⁷ (AUTHOR), Vassalotti, Joseph A.^8,9 (AUTHOR)

Source: Clinical Diabetes. Spring2025, Vol. 43 Issue 2, p227-239. 13p.

Long‐term health benefit and economic return of time in range (TIR) improvement in individuals with type 2 diabetes.

Authors: Alkhuzam, Khalid, Li, Piaopiao, Abuloha, Sumaya, Xue, Qiaochu, Shi, Lizheng, Fonseca, Vivian, Zhang, Yongkang, Shao, Hui

Source: Diabetes, Obesity & Metabolism; Mar2025, Vol. 27 Issue 3, p1564-1571, 8p

Subject Terms: BLOOD sugar monitors, NATIONAL Health & Nutrition Examination Survey, CONTINUOUS glucose monitoring, TYPE 2 diabetes, COST allocation

Progression of retinopathy with glucagon-like peptide-1 receptor agonists with cardiovascular benefits in type 2 diabetes – A systematic review and meta-analysis

Authors: Yoshida, Yilin, Joshi, Preeti, Barri, Saba, Wang, Jia, Corder, Amy L., O'Connell, Samantha S., Fonseca, Vivian A.

Source: In Journal of Diabetes and Its Complications August 2022 36(8)

Changes in body size phenotypes from childhood to adulthood and the associated cardiometabolic outcomes

Authors: Du, Tingting, Fonseca, Vivian, Chen, Wei, Bazzano, Lydia A.

Source: In Diabetes Research and Clinical Practice May 2022 187

Efficacy of iGlarLixi on 5-year risk of diabetes-related complications: A simulation study

Authors: Shao, Hui, Kianmehr, Hamed, Guo, Jingchuan, Li, Piaopiao, Fonseca, Vivian, Shi, Lizheng

Source: In Journal of Diabetes and Its Complications March 2022 36(3)

Menopausal hormone therapy and risk of cardiovascular events in women with prediabetes or type 2 diabetes: A pooled analysis of 2917 postmenopausal women

Authors: Yoshida, Yilin, Chen, Zhipeng, Baudier, Robin L., Krousel-Wood, Marie, Anderson, Amanda H., Fonseca, Vivian A., Mauvais-Jarvis, Franck

Source: In Atherosclerosis March 2022 344:13-19

DCRM Multispecialty Practice Recommendations for the management of diabetes, cardiorenal, and metabolic diseases

Authors: Handelsman, Yehuda, Anderson, John E., Bakris, George L., Ballantyne, Christie M., Beckman, Joshua A., Bhatt, Deepak L., Bloomgarden, Zachary T., Bozkurt, Biykem, Budoff, Matthew J., Butler, Javed, Dagogo-Jack, Samuel, de Boer, Ian H., DeFronzo, Ralph A., Eckel, Robert H., Einhorn, Daniel, Fonseca, Vivian A., Green, Jennifer B., Grunberger, George, Guerin, Chris, Inzucchi, Silvio E., Jellinger, Paul S., Kosiborod, Mikhail N., Kushner, Pamela, Lepor, Norman, Mende, Christian W., Michos, Erin D., Plutzky, Jorge, Taub, Pam R., Umpierrez, Guillermo E., Vaduganathan, Muthiah, Weir, Matthew R.

Source: In Journal of Diabetes and Its Complications February 2022 36(2)

Non-invasive diagnosis of nonalcoholic fatty liver disease in patients with type 2 diabetes

Authors: Alhinai, Alshaima ^a, Patel, Keyur ^b, Fonseca, Vivian A. ^c, Sebastiani, Giada ^{a, d, ⁎}

Source: In Journal of Diabetes and Its Complications September 2021 35(9)